2020
Cardiac Biventricular Metastasis From Renal Cell Carcinoma
Latifi AN, Ibe U, Arbune A, Kluger H, Baldassarre LA. Cardiac Biventricular Metastasis From Renal Cell Carcinoma. Cureus 2020, 12: e10870. PMID: 33178523, PMCID: PMC7652367, DOI: 10.7759/cureus.10870.Peer-Reviewed Original ResearchRenal cell carcinomaMetastatic renal cell carcinomaCardiac metastasisCell carcinomaRecurrent metastatic renal cell carcinomaCircumferential pericardial effusionSecondary cardiac tumorsAdvanced metastatic diseaseExtent of diseaseShortness of breathSite of involvementCardiac magnetic resonanceCardiac tumorsRespiratory failureMetastatic diseasePericardial effusionSystemic therapyBiventricular hypertrophyMultiple lesionsPrimary tumorPatient's diseaseTissue biopsiesMetastasisVentricular wallDisease
2019
Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment
Mills B, Connolly K, Ye J, Murphy J, Uccello T, Han B, Zhao T, Drage M, Murthy A, Qiu H, Patel A, Figueroa N, Johnston C, Prieto P, Egilmez N, Belt B, Lord E, Linehan D, Gerber S. Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment. Cell Reports 2019, 29: 406-421.e5. PMID: 31597100, PMCID: PMC6919969, DOI: 10.1016/j.celrep.2019.08.095.Peer-Reviewed Original ResearchConceptsStereotactic body radiation therapyMultiple preclinical mouse modelsPancreatic ductal adenocarcinoma patientsEffective neoadjuvant therapyAdvanced metastatic diseaseStereotactic body radiationDuctal adenocarcinoma patientsLate-stage diseaseInterferon-gamma productionBody radiation therapySystemic tumor immunityPreclinical mouse modelsNeoadjuvant approachNeoadjuvant therapyLiver metastasesMetastatic diseaseCD8 TTumor immunityAdenocarcinoma patientsImmune microenvironmentTumor reductionMS administrationTherapy resultsPancreatic tumorsGamma production
2018
An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
Guadalupe E, Deshpande H, Stein S. An update of lanreotide acetate for treatment of adults with carcinoid syndrome. Drugs Of Today 2018, 54: 457-465. PMID: 30209440, DOI: 10.1358/dot.2018.54.8.2834461.Peer-Reviewed Original ResearchConceptsSymptoms of carcinoid syndromeCarcinoid syndromeCarcinoid tumorsOrigin of carcinoid tumorsTreatment of carcinoid syndromeUrinary 5-hydroxyindoleacetic acidAdvanced metastatic diseaseSomatostatin analogue octreotideTreatment of adultsMetastatic diseaseSerotonin metaboliteAnalogue octreotideNative somatostatinDebilitating diarrheaLanreotide acetateSyndromeTumorSymptom controlLanreotideSlow-growingSymptomsSomatostatinTreatmentHalf-lifeChemotherapyProstate Cancer
Liaw B, Oh W. Prostate Cancer. 2018, 344-362. DOI: 10.1002/9781118592168.ch26.Peer-Reviewed Original ResearchProstate cancerAdvent of prostate-specific antigen screeningProstate-specific antigen screeningRoutine prostate cancer screeningAdvanced metastatic diseaseAdvanced prostate cancerProstate cancer therapyProstate cancer screeningMetastatic diseaseNonskin cancerAntigen screeningMechanism of actionCancer screeningCancer therapyClinical investigationRisk factorsCancerEarly detectionProstateCancer diagnosisTherapyOptimal timingScreeningDiagnosisDisease
1981
Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy.
Whang-Peng J, Lees D, Schuette W, Smith R, Bull J, DeVita V. Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. Journal Of The National Cancer Institute 1981, 65: 1103-4. PMID: 7296555.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply